Evidence map›Paper›PMID 36614215›Full record

ArticleInternational journal of molecular sciences2023

G-Protein-Coupled Receptors Mediate Modulations of Cell Viability and Drug Sensitivity by Aberrantly Expressed Recoverin 3 within A549 Cells.

Hanae Ichioka, Yoshihiko Hirohashi, Tatsuya Sato, Masato Furuhashi, Megumi Watanabe, Yosuke Ida, Fumihito Hikage, Toshihiko Torigoe, Hiroshi Ohguro

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Hanae IchiokaDepartments of Ophthalmology, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.
Yoshihiko HirohashiDepartments of Pathology, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.ORCID 0000-0002-0608-3914
Tatsuya SatoDepartments of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.ORCID 0000-0001-7876-1772
Masato FuruhashiDepartments of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.ORCID 0000-0002-0145-3541
Megumi WatanabeDepartments of Ophthalmology, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.ORCID 0000-0002-8026-6532
Yosuke IdaDepartments of Ophthalmology, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.ORCID 0000-0002-5165-6507
Fumihito HikageDepartments of Ophthalmology, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.ORCID 0000-0002-0124-5494
Toshihiko TorigoeDepartments of Pathology, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.ORCID 0000-0002-9463-5917
Hiroshi OhguroDepartments of Ophthalmology, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.
Sapporo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To elucidate the currently unknown molecular mechanisms responsible for the aberrant expression of recoverin (Rec) within cancerous cells, we examined two-dimensional (2D) and three-dimensional (3D) cultures of Rec-negative lung adenocarcinoma A549 cells which had been transfected with a plasmid containing human recoverin cDNA (A549 Rec) or an empty plasmid as a mock control (A549 MOCK). Using these cells, we measured cytotoxicity by several anti-tumor agents (2D), cellular metabolism including mitochondrial and glycolytic functions by a Seahorse bio-analyzer (2D), the physical properties, size and stiffness of the 3D spheroids, trypsin sensitivities (2D and 3D), and RNA sequencing analysis (2D). Compared with the A549 MOCK, the A549 Rec cells showed (1) more sensitivity toward anti-tumor agents (2D) and a 0.25% solution of trypsin (3D); (2) a metabolic shift from glycolysis to oxidative phosphorylation; and (3) the formation of larger and stiffer 3D spheroids. RNA sequencing analysis and bioinformatic analyses of the differentially expressed genes (DEGs) using Gene Ontology (GO) enrichment analysis suggested that aberrantly expressed Rec is most likely associated with several canonical pathways including G-protein-coupled receptor (GPCR)-mediated signaling and signaling by the cAMP response element binding protein (CREB). The findings reported here indicate that the aberrantly expressed Rec-induced modulation of the cell viability and drug sensitivity may be GPCR mediated.

Indexed as

Antineoplastic AgentsA549 CellsCell SurvivalHumansReceptors, G-Protein-CoupledRecoverinSpheroids, CellularTrypsinAntineoplastic AgentsReceptors, G-Protein-CoupledRecoverinTrypsin3D spheroid cultureGene Ontology (GO) enrichment analysisG-protein-coupled receptorsingenuity pathway analysis (IPA)melanomarecoverinRNA sequencing

Identifiers

PMID36614215
PMCPMC9820968
OpenAlexW4313473192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.